• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喉肿瘤的肿瘤形态与放疗即刻反应

Tumour morphology and radiotherapy immediate response in laryngeal tumours.

作者信息

Monteiro E, Varzim G, Lopes C, Ferreira E

机构信息

ORL Department, Portuguese Institute of Oncology, Porto, Portugal.

出版信息

An Otorrinolaringol Ibero Am. 2002;29(6):559-71.

PMID:12596349
Abstract

Laryngeal cancer is relatively frequent in South Europe countries and its incidence suffered variations in last decades. Treatment options are usually based on histology, T category and stage. Tumors unchain in neighbour tissues the presence of cells that normally are associated to inflammatory response. A possible association between tumour inflammatory response and radiotherapy efficacy is focused in occasional papers. Several histological parameters (histologic type, nuclear grade, desmoplasia, necrosis, and cells normally involved in inflammatory response) were analysed in biopsy material obtained from 67 patients with laryngeal cancer treated with primary radiotherapy in our department. Statistical analyses were made in order to assess a possible association between tumour morphology and radiotherapy response.

摘要

喉癌在南欧国家相对常见,其发病率在过去几十年有所变化。治疗方案通常基于组织学、T分类和分期。肿瘤在邻近组织中引发通常与炎症反应相关的细胞的出现。肿瘤炎症反应与放射治疗疗效之间的可能关联在一些偶尔发表的论文中有所探讨。我们科室对67例接受原发性放射治疗的喉癌患者的活检材料进行了分析,分析了几个组织学参数(组织学类型、核分级、纤维组织增生、坏死以及通常参与炎症反应的细胞)。进行了统计分析以评估肿瘤形态与放射治疗反应之间的可能关联。

相似文献

1
Tumour morphology and radiotherapy immediate response in laryngeal tumours.喉肿瘤的肿瘤形态与放疗即刻反应
An Otorrinolaringol Ibero Am. 2002;29(6):559-71.
2
Polymorphisms of the human OGG1 gene in laryngeal cancer: implications in radiotherapy response and survival.喉癌中人类OGG1基因多态性:对放疗反应和生存的影响
Rev Laryngol Otol Rhinol (Bord). 2005;126(3):135-40.
3
The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.表皮生长因子受体和E-钙黏蛋白在声门上型喉鳞状细胞癌放疗总治疗时间缩短的预后中的作用。
Acta Oncol. 2005;44(1):50-8. doi: 10.1080/02841860510007396.
4
The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?早期喉癌(T1-T2 N0)的治疗:手术还是放疗?
Head Neck. 2004 Feb;26(2):127-35. doi: 10.1002/hed.10361.
5
Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.伴有同步推量的加速超分割照射用于II期喉癌和局部晚期头颈癌。
Acta Otolaryngol Suppl. 2004 Oct(554):62-6. doi: 10.1080/03655230410018345.
6
Assessment of dendritic cell number and radiosensitivity in laryngeal tumours.喉肿瘤中树突状细胞数量及放射敏感性的评估
Clin Otolaryngol. 2005 Apr;30(2):164-8. doi: 10.1111/j.1365-2273.2004.00948.x.
7
Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.为何要在第3周开始对晚期喉癌进行加速放疗中的同步增敏治疗?
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):62-9. doi: 10.1016/j.ijrobp.2004.09.007.
8
Accelerated radiotherapy for advanced laryngeal cancer.晚期喉癌的加速放射治疗
Acta Oncol. 2005;44(5):481-9. doi: 10.1080/02841860510029950.
9
Predictors of local failure in early laryngeal cancer.早期喉癌局部失败的预测因素。
Neoplasma. 2005;52(6):483-8.
10
[Histological clinical features of the primary tumor as prognostic factors in patients with laryngeal carcinoma].[原发性肿瘤的组织学临床特征作为喉癌患者的预后因素]
Pol Merkur Lekarski. 2003 Jul;15(85):55-60.